Drugging the Undruggable Ras — Immunotherapy to the Rescue?

Metastatic gastrointestinal cancers that express products of mutant KRAS genes have one of the most dismal outcomes of all solid tumors and present an unsolved problem in cancer medicine. An activating point mutation in one of genes encoding Ras was the first somatic point mutation identified in a…

http://ift.tt/2gnqVoW